Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice.

Clinical and Experimental Immunology
J-J ChoiC-S Cho

Abstract

Mesenchymal stem cells (MSCs) have the inherent ability to migrate to multiple organs and to exert immunosuppressive activity. The aim of this study was to investigate the anti-arthritogenic effects of interleukin (IL)-10-transduced MSCs (IL-10-MSC) on the development of inflammatory arthritis. DBA/1 mice were immunized with type II collagen (CII) to induce inflammatory arthritis and then injected weekly three times with IL-10-MSCs 21 days after primary immunization. Control mice received vehicle or MSCs alone. Serum anti-CII antibody and T cell response to CII were determined. The results showed that cultured IL-10-MSCs were able to secrete high amounts of IL-10 in vitro. Injection of IL-10-MSCs decreased the severity of arthritis significantly. However, there was no difference in arthritis severity between mice treated with MSC and vehicle alone. Anti-CII antibody titres in the sera and T cell proliferative response to CII in lymph node cells were decreased significantly in mice treated with IL-10-MSCs compared with vehicle-treated mice. Serum IL-6 level was also decreased by the administration of IL-10-MSCs. In contrast, spleen cells of IL-10-MSC-treated mice produced higher amounts of IL-4 than those of control mice. Intere...Continue Reading

References

Dec 1, 1991·The Journal of Experimental Medicine·C BogdanC Nathan
May 1, 1994·The Journal of Experimental Medicine·P D KatsikisM Feldmann
Mar 1, 1996·Arthritis and Rheumatism·P IsomakiJ Punnonen
Mar 1, 1996·Arthritis and Rheumatism·M WalmsleyM Feldmann
Jan 7, 1998·Arthritis and Rheumatism·P Miossec, W van den Berg
Apr 2, 1999·Science·M F PittengerD R Marshak
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K N KimR Hirsch
Sep 6, 2000·Nature Biotechnology·H PetiteG Guillemin
Feb 2, 2002·Experimental Hematology·Amelia BartholomewRonald Hoffman
Aug 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Herbert TilgGünter Weiss
Apr 30, 2003·Arthritis Research & Therapy·Alison FinneganJian Zhang
May 7, 2003·Gene Therapy·C JorgensenD Noël
Oct 21, 2004·Blood·Sudeepta Aggarwal, Mark F Pittenger
Mar 22, 2005·Experimental Cell Research·Ida RasmussonKatarina Le Blanc
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Muzlifah A HaniffaMatthew P Collin

❮ Previous
Next ❯

Citations

Jul 24, 2010·Human Gene Therapy·Cynthia M ColemanJ Mary Murphy
Jun 30, 2009·Rheumatology·Carine BouffiChristian Jorgensen
May 23, 2014·PloS One·Wojciech BłogowskiTeresa Starzyńska
Jan 1, 2010·Clinical and Experimental Gastroenterology·Es Swenson, Nd Theise
May 25, 2011·World Journal of Stem Cells·Ju-Yeon KimJong Wook Chang
Nov 6, 2012·Clinical and Experimental Medicine·Yi LiuJinxiang Han
May 31, 2014·Stem Cells International·Andrea FariniYvan Torrente
Aug 29, 2014·Stem Cell Research & Therapy·Catherine B SullivanJosephine Mary Murphy
Aug 25, 2010·Best Practice & Research. Clinical Rheumatology·Alan Tyndall, Jacob M van Laar
Jun 8, 2011·Arthritis and Rheumatism·Gordon I A MacDonaldCosimo De Bari
May 28, 2010·Journal of Cellular Biochemistry·Diptiman ChandaSelvarangan Ponnazhagan
Dec 2, 2009·Journal of Cellular Biochemistry·Masanobu Ohishi, Ernestina Schipani
Dec 17, 2009·Clinical and Experimental Immunology·B ChenR C Zhao
Jan 12, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Carolyn A HolladayAbhay Pandit
Mar 26, 2011·Current Opinion in Biotechnology·David Sánchez-MartínLuis Álvarez-Vallina
Jan 9, 2013·Expert Opinion on Therapeutic Targets·Robert J MacFarlaneEleftherios Tsiridis
Feb 19, 2014·Human Vaccines & Immunotherapeutics·Gary ReynoldsCatharien M U Hilkens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.